USPTO serial 79193638
PRADAXA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 4, 2017
- Examiner
- WHITTAKER BROWN, TRACY
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRADAXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Boehringer Ingelheim Pharma GmbH & Co KG
Ingelheim, DE
Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
Boehringer Ingelheim Pharma GmbH & Co KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
Boehringer Ingelheim Pharma GmbH & Co KG
DE
Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Moskowitz
Max Moskowitz Ostrolenk Faber LLP845 THIRD AVENUE, 17th FloorNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases and disorders of the [ alimentary tract and metabolism, and ] blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system [ , musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
- Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
- Other trademarks owned by Boehringer Ingelheim Pharma GmbH & Co KG
- Other trademarks in Class 005
- Similar marks named PRADAXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 1, 2025 | NC71 | NOTICE OF CANCELLATION SEC. 71 E-MAILED | — |
| Dec 1, 2025 | C71T | CANCELLED SECTION 71 | — |
| May 5, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 9, 2024 | PUM2 | OFFICE ACTION ISSUED POU2 | — |
| Dec 5, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 8, 2024 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Sep 27, 2023 | PUMI | PROOF OF USE INTERIM ACTION ISSUED | — |
| Sep 22, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Mar 31, 2023 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| Mar 31, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 16, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 4, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 28, 2017 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 8, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 8, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 4, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 4, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 17, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 28, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 3, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 25, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 21, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 10, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 22, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 17, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |